Brought to you by 
Synthes and Lilly team up in orthopedics drug/biomaterials deal
27 May 2015
Executive Summary
Musculoskeletal device company Synthes Inc. and Eli Lilly & Co. are joining forces to develop new treatments for orthopedic conditions including osteoporosis and bone fractures.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com